tert-Butyl N-methyl-N-[2-(pyridin-2-yldisulfanyl)ethyl]carbamate

Catalog No. :
ACAJUX164
CAS No. :
954376-25-1
Molecular Formula :
C13H20N2O2S2
Molecular Weight :
300.45

IUPAC Name:tert-butyl methyl(2-(pyridin-2-yldisulfaneyl)ethyl)carbamate

tert-Butyl N-methyl-N-[2-(pyridin-2-yldisulfanyl)ethyl]carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$993.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl N-methyl-N-[2-(pyridin-2-yldisulfanyl)ethyl]carbamate
IUPAC Nametert-butyl methyl(2-(pyridin-2-yldisulfaneyl)ethyl)carbamate
MDL No.MFCD24470644
Molecular FormulaC13H20N2O2S2
Molecular Weight300.45
SMILESO=C(OC(C)(C)C)N(C)CCSSC1=NC=CC=C1
InChI KeyFUNKNZAFGJKWCL-UHFFFAOYSA-N
Synonymtert-butyl N-methyl-N-[2-(pyridin-2-yldisulfanyl)ethyl]carbamate;Carbamic acid, N-methyl-N-[2-(2-pyridinyldithio)ethyl]-, 1,1-dimethylethyl ester;tert-butyl methyl(2-(pyridin-2-yldisulfaneyl)ethyl)carbamate
CAS No.954376-25-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAJUX164 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGRWL908 route compound structure diagram
    ACGRWL908535943-48-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAJUX164 route product structure diagram
    ACAJUX164954376-25-1
Inquiry

2. ACAJUX164 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJZPX369 route compound structure diagram
    ACJZPX3691613113-41-9 In Stock
  4. Then
  5. ACAJUX164 route product structure diagram
    ACAJUX164954376-25-1
Inquiry

Comments (0)